• Press Release

BioMarin Announces Positive Data From Cerliponase Alfa Program for Treatment of CLN2 Disease, a Form of Batten Disease, at 12th Annual WORLDSymposium(TM) 2016

• Press Release

BioMarin to Present Research Results on Duchenne Muscular Dystrophy and Pompe Disease Programs at the 20th International Congress of the World Muscle Society

• Press Release

Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, From BioMarin

• Press Release

Forbes Ranks BioMarin 10th Most Innovative Company in the World

• Press Release

BioMarin Announces 2 Oral and 8 Poster Presentations at Lysosomal Disease Network’s 11th Annual WORLD Symposium(TM)

• News Post

Social Media Influencer Strives to Make Carnival Inclusive for All

• Press Release

Presentations at WORLD Symposium: Vimizim Phase 3 Results and BMN-701 Phase 1/2 Patient Demographics

• Press Release

BioMarin Announces 14 Presentations at 15th Annual WORLDSymposium™ 2019

• Page

Diversity, Equity and Inclusion Focus Areas

• Page

Learning and Development

• Publication

Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study

Gili Kenet, Yeu-Chin Chen, Gillian Lowe, Charles Percy, Huyen Tran, Annette von Drygalski, Marc Trossaert, Mark Reding, Johannes Oldenburg, Maria Eva Mingot-Castellano, Young-Shil Park, Flora Peyvandi, Margareth C. Ozelo, Johnny Mahlangu, Jennifer Quinn, Mei Huang, Divya B. Reddy, Benjamin Kim

• Publication

Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world

Charles M Lourenço, Andre Pessoa, Carmen C Mendes, Carolina Rivera-Nieto, Diane Vergara, Mónica Troncoso, Emily Gardner, Francisca Mallorens, Lina Tavera, Luis A Lizcano, Nora Atanacio, Norberto Guelbert, Norma Specola, Nury Mancilla, Carolina FM de Souza and Sara E Mole

• Publication

Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data

Melissa Lah, Keziah Cook, Dumingu Aparna Gomes, Stephanie Liu, Nadia Tabatabaeepour, Noam Kirson, Er Chen, Kristin Lindstrom, Kaleigh Bulloch Whitehall, Joost Van Backle, Barbara K. Burton

• Page

Achondroplasia Clinical Trials

• Page

Our Science

• Page

Patient Community Engagement

• Press Release

BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health

• Page

Supplier Information

• News Post

Family Camp Helps Create Community, Support Networks for People with PKU

• Press Release

BioMarin Announces New R&D and Business Development Leadership